Cybin Announces Results of Annual and Extraordinary Shareholders’ Meeting and Share Consolidation

Cybin Inc. (NYSE American: CYBN) (Cboe CA:CYBN) (Cybin” or the “Company”), a pioneering clinical-stage neuropsychiatric company committed to revolutionizing mental health care by developing novel and innovative next-generation treatment options, is pleased to announce the voting results for each of the matters presented at the Company’s annual and special meeting of shareholders held on August 27, 2024 (the “Meeting”). There were 87 shareholders represented in person or by proxy at the meeting holding 453,195,063 common shares, representing 59.66% of Cybin’s total issued and outstanding common shares as of the record date for the meeting. The voting results for each matter presented at the meeting are set forth below:

1. Appointment of the accountant